Companies: 48,687 Total Market Cap: 127281996338110.52

Shanghai Pharmaceuticals Holding Co., Ltd

SHA-601607
Healthcare Medical Distribution
Rank #2146
Market Cap 8.15 B
Volume 875,281.55
Price 2.47
Change (%) 0.11%
Country or region China China

Shanghai Pharmaceuticals Holding Co., Ltd's latest marketcap:

8.15 B

As of May 4, 2025, Shanghai Pharmaceuticals Holding Co., Ltd's market capitalization has reached $8.15 B. According to our data, Shanghai Pharmaceuticals Holding Co., Ltd is the 2146th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 8.15 B
Revenue (ttm) 37.93 B
Net Income (ttm) 597.21 M
Shares Out 3.71 B
EPS (ttm) 0.16
Forward PE 13.60
Ex-Dividend Date September 24, 2024
Earnings Date April 28, 2025
Market Cap Chart
Data Updated: May 4, 2025

Shanghai Pharmaceuticals Holding Co., Ltd's yearly market capitalization.

Shanghai Pharmaceuticals Holding Co., Ltd has seen its market value grow from ¥47.49 B to ¥59.24 B since 2020, representing a total increase of 24.74% and an annual compound growth rate (CAGR) of 5.24%.
Date Market Cap Change (%)
April 30, 2025 ¥59.24 B -14.63%
December 31, 2024 ¥69.40 B 23.68%
December 29, 2023 ¥56.11 B -6.6%
December 30, 2022 ¥60.07 B 21.91%
December 31, 2021 ¥49.28 B 3.76%
December 31, 2020 ¥47.49 B

Company Profile

Shanghai Pharmaceuticals Holding Co., Ltd.

Overview: Shanghai Pharmaceuticals Holding Co., Ltd. is a leading pharmaceutical and healthcare company engaged in research, development, manufacturing, distribution, and retailing of medical products across China and internationally.

Business Segments

  • Production: Manufactures pharmaceuticals and healthcare products.
  • Distribution: Provides pharmaceutical supply chain solutions.
  • Retail: Operates a network of retail pharmacy stores.
  • Others: Includes additional healthcare-related services.

Product Portfolio

The company offers a diverse range of products, including:

  • Chemicals and biochemicals
  • Chinese medicines
  • Healthcare products
  • Medical devices

Therapeutic Areas

Shanghai Pharmaceuticals serves multiple therapeutic areas, such as:

  • Cardiovascular and endocrinology
  • Oncology and anti-tumor treatments
  • Neurological and autoimmune disorders
  • Respiratory and digestive system conditions
  • Anti-inflammatory and antiviral solutions

Additional Services

The company provides:

  • Pharmaceutical distribution and warehousing
  • Logistics and supply chain solutions
  • Value-added services for hospitals and pharmacies

Founded: 1994

Headquarters: Shanghai, China

Frequently Asked Questions

As of May 4, 2025, Shanghai Pharmaceuticals Holding Co., Ltd (including the parent company, if applicable) has an estimated market capitalization of $8.15 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Shanghai Pharmaceuticals Holding Co., Ltd global market capitalization ranking is approximately 2146 as of May 4, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region China
Founded 1994
IPO Date n/a
Employees 49,402
CEO Bo Shen
Sector Healthcare
Industry Medical Distribution
Address Shanghai Pharmaceutical Building
Shanghai, 200020
China